|
|
||||||||
From the Sections of Neurology (J.R., P.P.), Neuro-Rehabilitation (C.J.), and the ALS Clinic at Virginia Mason (J.R., P.P., C.J.), Virginia Mason Medical Center, Seattle; and Neurogenomics Laboratory (J.R.), Benaroya Research Institute at Virginia Mason, Seattle, WA.
Address correspondence and reprint requests to Dr. John Ravits, Neurogenomics Laboratory, Benaroya Research Institute at Virginia Mason, 1201 Ninth Avenue, Seattle, WA 98101 john.ravits{at}vmmc.org
Objective: To localize and analyze the anatomic distribution of upper motor neuron (UMN) and lower motor neuron (LMN) loss in patients with ALS early in their disease when motor manifestations were still relatively focal using clinical examination signs.
Methods: We reviewed records of 100 patients with ALS who were evaluated when the diagnosis was first established or suspected. From the patient history, we ascertained the body region of first symptoms and the time course. From the physical examination, we separately graded severity of UMN and LMN signs in each body region, indexed these to the body region of first symptoms, and sorted and analyzed the data.
Results: Motor manifestations began in one body region in 98% of patients. UMN and LMN signs were both maximal in these same body regions, but they were independent of each other in severity and their outward distribution, which conformed to neuronal anatomy. The outward distribution of both UMN and LMN signs seemed more directed to caudal body regions than to rostral ones.
Conclusions: Motor neuron degeneration in ALS is a focal process at both upper and lower motor neuron levels of the motor system. At each level, it begins corresponding to the same peripheral body region and then advances contiguously and separately to summate over time.
See also page 1576
Supplemental dataat www.neurology.org
Supported by grants from the National Institute of Neurological Diseases and Stroke (NS051738), Juniper Foundation, Moyer Foundation, and Benaroya Foundation.
Disclosure: The authors report no conflicts of interest.
Presented at the 17th International Symposium on ALS/MND, November 30, 2006, Yokohama, Japan.
Received June 23, 2006. Accepted in final form December 7, 2006.
Related Article
Neurology 2007 68: 1576-1582.
This article has been cited by other articles:
![]() |
C. Armon From clues to mechanisms: Understanding ALS initiation and spread Neurology, September 16, 2008; 71(12): 872 - 873. [Full Text] [PDF] |
||||
![]() |
M. Sabatelli, F. Madia, A. Conte, M. Luigetti, M. Zollino, I. Mancuso, M. Lo Monaco, G. Lippi, and P. Tonali Natural history of young-adult amyotrophic lateral sclerosis Neurology, September 16, 2008; 71(12): 876 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kuhnlein, A.-D. Sperfeld, B. Vanmassenhove, V. Van Deerlin, V. M.-Y. Lee, J. Q. Trojanowski, H. A. Kretzschmar, A. C. Ludolph, and M. Neumann Two German Kindreds With Familial Amyotrophic Lateral Sclerosis Due to TARDBP Mutations Arch Neurol, September 1, 2008; 65(9): 1185 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ravits, P. Laurie, Y. Fan, and D. H. Moore Implications of ALS focality: Rostral-caudal distribution of lower motor neuron loss postmortem Neurology, May 8, 2007; 68(19): 1576 - 1582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |